The Japan TimesSep 24, 2024
Japan's health ministry on Tuesday approved the production and sale of a new medicine for ALS, raising hopes among patients. https://www.japantimes.co.jp/news/2024/09/24/japan/science-health/japan-new-als-drug-approve/ #japan #sciencehealth #als #eisai #mecobalamin
Japan approves sale of new ALS drug, raising hopes among patients

The drug, mecobalamin, extended the survival period of patients within a year of the onset of ALS by over 500 days, surpassing existing drugs.

The Japan Times